Federal regulators

  Another Johnson & Johnson Facility Substandard Practices. Another manufacturing facility operated by a Johnson & Johnson concern has been cited by federal regulators for substandard manufacturing practices. This time, [...]

  OTC Pain Killers Safety Warnings. The makers of over-the-counter (OTC) pain medications and fever reducers have been told by federal regulators to include new warnings on their labels about [...]

Genzyme Received FDA Warning Letter. Biotech giant, Genzyme Corporation, has received a warning letter over what federal regulators are describing as “significant objectionable conditions” at its Boston manufacturing plant, reports [...]

Singulair Safety Review. Federal regulators said today that they are continuing a probe into the psychiatric side effects of Singulair and similar asthma drugs. The Food & Drug Administration (FDA) [...]

Byetta Probe Extension Sought. Federal regulators are extending a review of the diabetes drug Byetta into next year, Forbes.com is reporting. The Food & Drug Administration (FDA) is considering whether [...]

  Byetta Implicated In Deaths. Byetta has been implicated in six deaths, four more than federal regulators reported last week.  The additional deaths were revealed late yesterday during a conference [...]

  Epilepsy Drugs New Suicide Warning. Federal regulators are considering new suicide warnings for some epilepsy drugs, but the pharmaceutical companies that make the medications are desperately trying to quash [...]

  FDA To Go After Fake Medical Device. Fake medical devices have finally gotten the attention of federal regulators. In a collaborative move with foreign governments, the Food and Drug Administration [...]

60 deaths in patients implanted with the device. Federal regulators are linking Johnson & Johnson’s blockbuster Cypher stent to more than 60 deaths in patients implanted with the device, according to [...]